Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01289717 · ClinicalTrials.gov registry record
Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant Recipients
A clinical trial of Kidney Transplantation and Kidney Transplant, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 307
- Enrollment target
- 5
- Study locations
NCT01289717 is a study of Kidney Transplantation and Kidney Transplant that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 307 participants, above the 259-participant average among 33 other Kidney Transplantation trials with a reported enrollment target (19% higher). The trial reports 5 study locations across 5 states.
The verdict
NCT01289717, a study of Kidney Transplantation and Kidney Transplant, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 307 participants
- Enrollment target
- 5
- Study locations
Study Summary
There is a need to develop blood and/or urine tests that will help to detect early signs of rejection in people who have had kidney transplant. Researchers will examine blood, urine, and tissue samples and try to identify genetic markers for certain conditions like rejection, response to therapy, and scarring of the kidney. By studying gene patterns, researchers hope to be able to diagnose these conditions earlier and improve kidney survival.
Conditions Studied
Study Locations (5)
Arizona
- Mayo Clinic, Division of Nephrology - Phoenix
California
- The Scripps Research Institute, Scripps Center for Organ and Cell Transplantation, - La Jolla
Illinois
- Northwestern University, Feinberg School of Medicine, Division of Organ Transplantation - Chicago
Ohio
- The Cleveland Clinic - Cleveland
South Carolina
- Medical University of South Carolina, Division of Transplant - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 307 participants |
| Start Date | 2011-03 |
| Est. Completion | 2016-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01289717
The ClinicalTrials.gov registry entry for NCT01289717 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 307 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 259-participant average among 33 other Kidney Transplantation trials with a reported enrollment target (19% higher). The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Kidney Transplantation appearing as the primary indexed condition, and to 0 interventions.
NCT01289717 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Arizona, California, Illinois.
Frequently Asked Questions
What is clinical trial NCT01289717 about?
NCT01289717 is a clinical study titled "Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant Recipients". There is a need to develop blood and/or urine tests that will help to detect early signs of rejection in people who have had kidney transplant. Researchers will examine blood, urine, and tissue samples and try to identify genetic markers for certain conditions like rejection, response to therapy, an...
What is the current status of trial NCT01289717?
This trial is currently completed. The enrollment target is 307 participants. The study started on 2011-03. Estimated completion is 2016-06.
What conditions does trial NCT01289717 study?
This clinical trial studies the following conditions: Kidney Transplantation, Kidney Transplant.
Who is sponsoring clinical trial NCT01289717?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01289717 being conducted?
This trial has 5 study locations across Arizona, California, Illinois, Ohio, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial.
RECRUITING · Phase 4
-
Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision
RECRUITING · NA
-
Prehabilitation for Kidney Transplant Candidates
RECRUITING · NA
-
REgulatory T Cell Therapy to Achieve Immunosuppression REduction
RECRUITING · Phase 2
-
Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation
RECRUITING · Phase 2
-
Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.